ИАПФ в реальной практике: неравенство равных


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Доступ платный или только для подписчиков

Аннотация

Препараты на основе ингибиторов ангиотензинпревращающего фермента (ИАПФ) обладают индивидуальными фармакокинетическими свойствами, которые могут определять различия в тканевой концентрации ИАПФ и их разные клинические эффекты.

Полный текст

Доступ закрыт

Об авторах

Т. Чернявская

МГМСУ им. А.И. Евдокимова

Email: corona1974@mail.ru
кандидат медицинских наук

Список литературы

  1. The Six Report of the Jiont National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure // Arch. Intern. Med. - 1997; 157: 2413-46.
  2. WHO - OSH Hypertension Guidelines Committee. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension // J. Hypertens. - 1999; 17: 151-83.
  3. Agabiti-Rosei E., Ambrosioni E., Fimardi G. et al. Perindopril versus captopril: efficacy and acceptability in an Italian multicenter trial // Amer. J. Med. - 1992; 92: 79-83.
  4. Neal B., MacMahon S., Chapman N. Blood Pressure Lowering Treament Trialists'Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure lowering drugs: Results of prospectively designed overviews of randomised trials // Lancet. - 2000; 356: 1955-64.
  5. Heran B.S., Wong M.M., Heran I.K. et al. Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension // The Cochrane Collaboration. Cochrane database of Systematic Reviews. - 2008; 4. Art. No.:CD003823.D0I:10.1002/14651858.CD003823.pub2
  6. Gerbrandt K.R., Yedinak K.C. Formulary management of ACE inhibitors // Pharmacoeconomics. - 1996; 10 (6): 594-613.
  7. Turnbull F. Blood Pressure Lowering Treatment Trialists'Collaboration. Effects of different blood pressure lowering regimens on major cardiovascular events: Results of prospectively designed overviews of randomised trials // Lancet. - 2003; 362: 1527-35.
  8. Schwartzkopff B., Brehm M., Mundhenke M. et al. Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease // Hypertension. - 2000; 36: 220-5.
  9. Thybo N.K., Stephens N., Cooper A. et al. Effect of antihypertensive treatment on small arteries of patients with previously untriated essential hypertension // Hypertension. - 1995; 25: 474-81.
  10. Филатова Н.П. Применение периндоприла (престариума) при артериальной гипертонии // Тер. арх. - 1995; 67 (9): 81-3.
  11. Asmar R., Topouchian J., Crisan O. et al. Reversion of arterial abnormalities by long-term antihypertensive therapy in large population. The Compilor study // Eur. Heart J. - 2000; 21 (Suppl.): 2366.
  12. Zannad F., Bernaud C.M., Fay R. Double-blind, randomized multicentre comparison of the effects of amlodipine and perindopril on 24-h therapeutic coverage and beyond in patients with mild to moderate hypertension. General Physicians Investigators’ Group // Hypertension. - 1999; 17: 137-46.
  13. Терещенко С.Н., Дроздов В.Н., Демидова И.В. и др. Ингибитор ангиотензинпревращающего фермента периндоприл при лечении застойной сердечной недостаточности // Тер. арх. - 1997; 69 (7): 53-6.
  14. Lees K.R., Reid J.L., Scott M.G. et al. Captopril versus perindopril: a double blind study in essential hypertension // Hypertension. - 1989; 3: 17-22.
  15. Grandi A.M., Venco A., Barzizza F. et al. Double-blind comparison of perindopril and captopril in hypertension: effects on left ventricular morphology and function // Hypertension. - 1991; 4: 516-20.
  16. Lees K.R., Reid J.L., Scott M.G. et al. Captopril versus perindopril: a double blind study in essential hypertension // Hypertension. - 1989; 3: 17-22.
  17. Yoshinara K., Sarut T., Abe K. et al. Clinical evalution of monotherapy with perindopril, an ACE inhibitor in the treatment of essential hypertension: double-blind parallel comparison with enalapril // Rinsho Iyaku. - 1997; 13: 4259-97.
  18. Fox K.M., Henderson J.R., Bertrand M.E. et al. The European Trial on Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease (EUROPA) // Eur. Heart J. - 1998; 19 (Suppl. J): 52-5.
  19. Cleland J.G., Tendera M., Adamus J. et al. Perindopril for the elderly people with chronic heart failure: the PEP-CHF study // Eur. J. Heart Fail. - 1999; 1: 211-7.
  20. Baptista T. et al. Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: A multicentric, double-blind, placebo-controlled trial // Schizophr. Res. - 2007; 93:99-108.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ИД "Русский врач", 2013